Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography

[1]  O. Hoekstra,et al.  Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera , 1992, European Journal of Nuclear Medicine.

[2]  O. Hoekstra,et al.  Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  P. Stomper,et al.  Abdominal staging of thoracic Hodgkin disease: CT-lymphangiography-Ga-67 scanning correlation. , 1993, Radiology.

[4]  S M Larson,et al.  Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  H. Royal.  Clinical applications of positron emission tomography in cancer: the good, the bad and the ugly. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  J. Armitage,et al.  Autotransplantation in lymphoma: better therapy or healthier patients? , 1991, Annals of internal medicine.

[7]  J. Armitage,et al.  Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  M. Hirsh,et al.  Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: Significance and management , 1989 .

[9]  B. Hutton,et al.  Gallium scanning in the management of mediastinal Hodgkin's disease , 1989, European journal of haematology.

[10]  J. Armitage,et al.  Interpretation of clinical trials in diffuse large-cell lymphoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Umberto Vitolo,et al.  Predictive value of the early response to chemotherapy in high‐risk stages II and III Hodgkin's disease , 1987, Cancer.

[12]  R Paul,et al.  Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  D. Weisenburger,et al.  Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  D. Rosenthal,et al.  The significance of the residual mediastinal mass in treated Hodgkin's disease. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.